Brief: Agile Therapeutics Announces Peer Reviewed Publication Of Phase 3 SECURE Study Results For Twirla Transdermal System In Contraception
30/11/2020 14:13
Nov 30 (Reuters) - Agile Therapeutics Inc AGRX.O :
* AGILE THERAPEUTICS ANNOUNCES PEER-REVIEWED PUBLICATION OF
PHASE
3 SECURE STUDY RESULTS FOR TWIRLA® (LEVONORGESTREL AND ETHINYL
ESTRADIOL) TRANSDERMAL SYSTEM IN CONTRACEPTION
Source text for Eikon: ID:nGNXb2gypT
Further company coverage: AGRX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Agile Therapeutics
See all newsBrief: Agile Therapeutics Inc. Announces Definitive Merger Agreement With Insud Pharma, S.L.
Agile Therapeutics Inc expected to post a loss of 92 cents a share - Earnings Preview
Brief: Agile Therapeutics Announces Delisting From Nasdaq
Agile Therapeutics Inc expected to post a loss of 54 cents a share - Earnings Preview
Brief: Agile Therapeutics Completes Pay-Off Of Debt